Tata pharma mutual fund
WebApr 12, 2024 · Tata India Pharma & HealthCare Fund - Regular Plan Value Research Analyst’s Choice Riskometer Very High Value Research Rating Unrated ₹16.1575 0.36% … WebApr 4, 2024 · Tata India Pharma & Healthcare Fund holds 98.21% investment in domestic equities across large cap, mid cap and small cap companies in the pharma sector. NAV: …
Tata pharma mutual fund
Did you know?
WebBy submitting my personal details on this portal, I hereby authorise Tata Mutual Fund, Tata Asset Management Limited and/or its authorized service provider(s)to communicate … Web2 days ago · Meeta Shetty, fund manager at Tata Mutual Fund manages Rs 12,363 crore under six funds such as Tata Digital India, Tata Focused Equity, Tata India Pharma & Healthcare and Tata Large & Mid Cap.
WebApr 12, 2024 · Get the latest information and complete track record of 'Tata Resources & Energy Fund - Regular Plan' schemes, returns, latest NAV and ratings from independent mutual fund research house. The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in eq. Tata Resources & Energy Fund ... Web2 days ago · The direct plan of Tata Small Cap Fund has given a return of 44.79% while the regular plan has given a return of 42.17% in three years. The scheme tracks NIFTY …
WebMar 29, 2024 · Tata India Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run. Key parameters 1) Tata India Pharma & Healthcare Fund Direct Growth has a NAV of ₹ 17.7448 as on 29-03-2024. WebMar 22, 2024 · Tata India Pharma & HealthCare Fund Regular-Growth Unrated NAV as of Mar 22, 2024 15.59 0.99% Growth - Regular (Earn upto 1.43% Extra Returns with Direct Plan) Fund Category: Equity: Sectoral-Pharma Expense Ratio: 2.44% (1.54% Category average) Fund Size: Rs. 485.91 Cr (3.65% of Investment in Category) ADD TO …
WebMar 17, 2024 · Tata India Pharma & Healthcare Fund - Direct Plan-Growth This fund was launched on 28 December 2015. It is an open-ended Sectoral-Pharma mutual fund scheme from Tata Mutual...
WebApr 12, 2024 · Tata India Pharma & Heathcare Fund - Growth Regular Direct Category : Sectoral/Thematic Fund House : Tata Mutual Fund NAV : ₹ 16.1575 0.36% (as on 10th … the dungenessWebThis is an Equity Sectoral/Thematic, Pharma fund with S&P BSE HEALTHCARE (TRI) as its benchmark. The risk level for this fund is categorized as Very High Risk. Total AUM ₹ 1,202.1 crores as of Mar 31, 2024 Age of Fund 4 years 4 months since Nov 30, 2024 Expense Ratio 2.15% as of Apr 06, 2024 Exit Load 1% upto 12 Months Ideal holding period the dungeness spitWebApr 12, 2024 · Tata India Pharma & Healthcare Fund is an open-ended equity scheme that predominantly invests in equity & equity related instruments of companies from Pharma … Tata Mutual Fund Tata Asset Management Pvt. Ltd Mulla House, Ground Floor, … Download the Mutual Fund Annual Reports and Half Yearly Financial Report for … the dung beetle street outlaws motorWebApr 6, 2024 · UTI Healthcare Fund Regular Plan-Growth Fund Key Highlights 1. Current NAV: The Current Net Asset Value of the UTI Healthcare Fund - Regular Plan as of Apr 06, 2024 is Rs 145.59 for Growth option of its Regular plan. 2. Returns: Its trailing returns over different time periods are: -9.97% (1yr), 20.74% (3yr), 10.88% (5yr) and 13.06% (since … the dungeness crab \\u0026 seafood festivalWebMar 31, 2024 · Investment Objective: The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of pharma and other associated companies. Fund Performance Growth Plan - Growth Option Latest NAV (05 Apr 2024) 272.8990 Returns NAVs the dungeon beneath 3dmWeb5 Year Return: 5.94% INVEST NOW Debt Fund PARTNERED BY Canara Robeco Savings Fund - Direct Plan (G) 3 Year Return: 5.43% 5 Year Return: 6.41% INVEST NOW Debt Fund PARTNERED BY Canara Robeco... the dungeon beneath 1.3.3Web22 hours ago · Also Read: Best Mid Cap Funds in 3 years (April 2024): Top 11 mutual funds with 35% returns Nippon India Small Cap Fund. The direct plan of Nippon India Small Cap Fund has given a return of 16.59% ... the dungeon anarchist cookbook